Efecto protector del Phlebodium Decumanum sobre la fatiga muscular inducida por el ejercicio en sujetos no entrenados

  1. González-Jurado, J. A.
  2. Guisado Barrilao, Rafael
  3. Molina Sotomayor, Edgardo
  4. de Teresa Galván, Carlos
Revista:
Cultura, ciencia y deporte

ISSN: 1696-5043

Ano de publicación: 2008

Volume: 3

Número: 8

Páxinas: 101-106

Tipo: Artigo

DOI: 10.12800/CCD.V3I8.186 DIALNET GOOGLE SCHOLAR lock_openDialnet editor

Outras publicacións en: Cultura, ciencia y deporte

Resumo

The aim of this study was to evaluate if the consumption of a preparation from Phlebodium Decumanum, had beneficial effects on muscular fatigue indicators. Thirty-one healthy subjects were randomised to Phlebodium Decumanum (18 men; age: 22.1± 1.81 years; weight: 74.21±8.74 kg.)(PD Group), or placebo (13 men; age:: 22.5 ±1.63 years; weight: 78 ±12.5 kg.) (P Group). Both groups performed a standard physical training program during one month, three times a week. CK and LDH measures were evaluated before (pre-training) and 24 hours after finishing the training program (post-training) to study muscle damage induced by exercise. CK levels increased significantly in G.P (pretest 158±80.1, postest 254±158.1; p<0.05), but, in the other hand, in G.PD there was a CK levels decrease, almost achieving statistically significance (pretest 176.3±93.8, postest 149.6±66; p=0.08). LDH levels increased significantly in both groups, although this elevation was less evident in G.PD group (pretest 295.8±64.4, postest 324.1±48.1; p<0.01) that in G.P (pretest 295.7±65, postest 336.2±63; p<0.05). In conclusion, Phlebodium Decumanum can collaborate in the prevention of muscle damage induced by intense exercise, based on the results obtained in muscle enzymes levels in G.PD group.

Referencias bibliográficas

  • Chen, TC. & Hsieh, S.S. (2001). Effects of a 7 day eccentric training period on muscle damage and inflammation. Medicine and Science in Sports and Exercise, 33, (10), 1732-1738.
  • Córdova, A. & Álvarez-Mon, M. (1999a). Aspectos fisiopatológicos del daño y la fatiga muscular. Medicine, 127, 5989-94.
  • Córdova, A. & Álvarez-Mon, M. (1999b) El sistema inmune II: importancia de los inmunomoduladores en la recuperación del deportista. Archivos de Medicina del Deporte, 70, 155- 165.
  • Córdova, A. & Álvarez-Mon, M. (2001). La inmunidad en el deporte. Madrid: Gymnos; 203.
  • Edwards, R.H.T. (1981). Human Muscle Fatigue. London: Pitman medical; 1-18
  • Fry, RW., Morton, AR. & Keast, D. (1991). Overtraining in athletes. An update. Sports Medicine, 12(1), 32-65.
  • García, JM. (1999). La fuerza. Madrid: Gymnos. García, J.M., Navarro, M. & Ruiz, J.A. (1996). Bases teóricas del entrenamiento deportivo: Principios y Aplicaciones. Madrid: Gymnos.
  • Gleeson, M. (2002). Biochemical and immunological markers of overtraining. Journal of Sports Science and Medicine, 2, 31- 41.
  • Itoh, H., Ohkuwa, T., Yamazaki, Y., Shimoda, T., Wakayama, A. & Tamura, S. (2000). Vitamin E supplementation attenuates leakage of enzumes following 6 successive days of running training. International Journal of Sports Medicine, 21(5), 369-374.
  • Knitter, A.E., Panton, J.A. & Rathmacher, A. (2000). Effects of αhydroxy-β-methylbutyrate on muscle damage after a prolonge run. Journal of Applied Physiology, 89, 1340-1344.
  • Lee, J., Goldfarb, AH., Rescino, M., Hegde, S., Patrick, S. & Apperson, K. (2002). Eccentric exercise effect on blood oxidativestress markers and delayed onset of muscle soreness. Medicine and Science in Sports and Exercise, 34(3), 443-448.
  • Nosaka, K. & Newton, M. (2002). Repeated eccentric exercise bouts do not exacerbate muscle damage and repair. Journal of Strength and Conditioning Research, 16(1), 117-122.
  • Nosaka, K., Sakamoto, K., Newton, M. & Sacco, P. (2001). The repeated bout effect of reduced-load eccentric exercise on elbow flexor muscle damage. European Journal of Applied Physiology, 85(1-2), 34-40.
  • Punzón, C., Alcaide, A. & Fresno, M. (2003). In vitro anti-inflammatory activity of phlebodium decumanum. Modulation of tumor necrosis factor and slolubel TNF receptors. Innternational Immnunopharmacology, 3,1293-1299.
  • Remacha, A.F., Ordóñez, A. & Vinuesa, F. (1997). Adaptación bioquímica y hematológica al esfuerzo máximo en corredores de largas distancias. Apunts, Vol. XXXII, 243-269.
  • Rokitzki, L., Logemann, E. Hubber, G., Keck, E. & Keul, J. (1994). Alpha-tocopherol supplementation in racing cyclists during extreme undurance training. Internatioanl Journal Sport Nutrition, Sep. 4(3), 253-264.
  • Shave, R., Dawson, E., Whyte, G., George, K., Ball, D., Collinson, P. & Gaze, D. (2002). The cardiospecificity of the third-generation cTnT assay after exercise-induced muscle damage. Medicine and Science in Sports and Exercise, 34(4), 651-654.
  • Tuominen, M., Bohlin, L. & Rolfsen, W. (1992). Effects of Calaguala and an active principle, adenosine, on platelet activating factor. Planta Medica, 58(4), 306-310
  • Vasange, M., Liu, B., Welch, C.J., Rolfsen, W. & Bohlin, L. (1997a). The flavonoid constituents of two Polypodium species (Calaguala) and their effect on the elastase release in human neutrophils. Planta Medica, 63(6), 511-517.
  • Vasange, M., Rolfsen, W. & Bohlin, L. (1997b). A sulphonoglycolipid from the fern Polypodium decumanum and its effect on the platelet activating-factor receptor in human neutrophils. Journal of Pharmacy and Pharmacology, 49(5), 562-566.
  • Vasange, M., Tuominen, M., Perera-Ivarsson, P., Shen, J., Bohlin, L. & Rolfsen, W. (1994). The fern Polypodium decumanum, used in the treatment of psoriasis, and its fatty acid constituents as inhibitors of leukotriene B4 formation. Prostaglandins Leukot Essent Fatty Acids. 50(5), 279-284.
  • Vollestad, N. & Sejersted, OM. (1988). Biochemical correlates of fatigue. European Journal of Applied Physiology, 57, 336-347.
Fonte de datos: Dialnet